Shares of Manulife Financial Corporation MFC closed at $36.59 on Thursday, near its 52-week high of $38.72. This proximity underscores investor confidence. It has the ingredients for further price appreciation. The stock is trading above the 50-day and 200-day simple moving averages (SMA) of $35.65 and $33.49, respectively, indicating solid upward momentum. SMA is a widely used technical analysis tool to predict future price trends by analyzing historical price data.
With a market capitalization of $61.33 billion, the average volume of shares traded in the last three months was 2.4 million.
Image Source: Zacks Investment Research
MFC is an Outperformer
Shares of Manulife Financial have risen 30.5% in the past year, outperforming the industry, the Finance sector and the Zacks S&P 500 index’s growth of 17.1%, 18.9% and 30.1%, respectively.
Manulife Financial has outperformed its peers, Reinsurance Group of America, Incorporated RGA, Sun Life Financial Inc. SLF and Primerica, Inc. PRI. RGA, SLF and PRI have gained 17.2%, 19% and 4.6%, respectively, in the past year.
Image Source: Zacks Investment Research
The life insurer has a solid track record of beating earnings estimates in two of the past four quarters and missing in the other two, with an average surprise of 3.63%.
Average Target Price for MFC Suggests Upside
Based on short-term price targets offered by 12 analysts, the Zacks average price target is $40.82 per share. The average suggests a potential 11.8% upside from the last closing price.
Image Source: Zacks Investment Research
MFC’s Growth Projection Encourages
The Zacks Consensus Estimate for Manulife Financial’s 2026 earnings per share indicates a year-over-year increase of 8.9%. The estimate for 2027 earnings per share and revenues indicates an increase of 8.5% and 3.6%, respectively, from the corresponding 2026 estimates.
Optimist Analyst Sentiment on MFC
One of the two analysts covering the stock has raised estimates for 2026 and 2027 over the past 60 days. The Zacks Consensus Estimate for 2026 and 2027 earnings has moved up 1.2% and 1.1%, respectively, in the past 60 days.
Manulife Financial’s Higher Return on Capital
Return on equity in the trailing 12 months was 16.4%, better than the industry average of 15.6%. This highlights the company’s efficiency in utilizing shareholders’ funds.
Key Points to Note for MFC
Manulife is aggressively developing its business in Asia, which, in turn, is reaping solid operational results. Asia is a major contributor to the company’s earnings. New business growth in Asia has been aiding the company’s operational results. Thus, the insurer is continually scaling up its business across Asia. We believe MFC is well-positioned to benefit from continued business growth momentum, higher expected earnings on insurance contracts and higher expected investment earnings, with notable growth from the largest in-force business, Hong Kong and an expanding distribution network.
Manulife Financial is expanding its Wealth and Asset Management business and has identified Europe (and the wider EMEA market) as a significant growth area. It is making long-term investments in this region.
MFC has been accelerating growth in the highest-potential businesses. Its inorganic growth is impressive, as this life insurer prudently deploys capital in high-growth, less capital-intensive and higher-return businesses.
Banking on its sturdy capital position, MFC distributes wealth to shareholders through higher dividends and share buybacks. The company has increased its dividend at a seven-year CAGR of 10% and targets a 35-45% dividend payout over the medium term.
MFC is strengthening its balance sheet and thus targets a leverage ratio of 25%. Its free cash flow conversion has remained more than 100% over the last few quarters, reflecting its solid earnings.
End Notes
Manulife Financial is set to grow on solid Asia business, growing Wealth and Asset Management business, strong free cash flow conversion ratio and a solid capital position. A medium-term expense efficiency ratio target of less than 45%, banking on diligent expense management, should drive growth.
Consistent wealth distribution makes it an attractive pick for yield-seeking investors, and favorable ROE also poises. Coupled with optimistic analyst sentiment and favorable growth estimates, the time appears right for potential investors to bet on this Zacks Rank #2 (Buy) insurer. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Zacks Names #1 Semiconductor Stock
This under-the-radar company specializes in semiconductor products that titans like NVIDIA don't build. It's uniquely positioned to take advantage of the next growth stage of this market. And it's just beginning to enter the spotlight, which is exactly where you want to be.
With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $971 billion by 2028.
See This Stock Now for Free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Manulife Financial Corp (MFC): Free Stock Analysis Report
Reinsurance Group of America, Incorporated (RGA): Free Stock Analysis Report
Primerica, Inc. (PRI): Free Stock Analysis Report
Sun Life Financial Inc. (SLF): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).